A state of the art plasma fractionation facility would come up in Ahmedabad by early next year, providing boost to patients with immune disorders or severe blood loss.
Two companies, Celestial Biologicals Ltd (CBL) and GE Healthcare, have signed an MoU to set up the facility. The agreement was signed during the Vibrant Gujarat Global Investors' Summit that concluded in Ahmedabad last week.
The collaboration will include appropriate technology, products, processes and project development for establishing the facility, a release said in Ahmedabad.
Human plasma, a liquid component of blood, is the source of many life-saving proteins. A large number of these proteins can be isolated and used in medicine. The process of extracting and purifying these proteins is known as plasma fractionation. Currently, plasma products are imported.
Celestial Biologicals is investing Rs 100-120 crore to develop the centre, while GE Healthcare will be providing its purifying technologies, processes and support, it said.
CBL, an associate company of Intas Biopharmaceuticals, said the unit would be Good Manufacturing Practice (GMP)compliant.
GE Healthcare has been chosen as the partner for the project for its technological expertise and platform solution.
"As there was a requirement for a diverse range of solutions and process support, GE Healthcare demonstrated an attractive proposition," said Urmish Chudgar, Managing Director, Intas Biopharmaceuticals.
It is estimated that one million litres of plasma is required annually in India to meet current clinical demands. Hence, local manufacturing is the key to providing plasma products at affordable prices to patients in India, he said.
Apart from uplifting the overall transfusion medicine in India, the facility will help India become a major hub for plasma products in the SAARC region, Chudgar said.
The companies will jointly set up a pilot plasma fractionation centre of approximately 15,000 litres-40,000 litres capacity for at least four persons at CBL's existing GMP compliant facility, the release said.